⌘K

Login Start Free

Home/Filings/5/0001570523-18-000013

5//SEC Filing

DAILEY ROBERT JACKMAN 5

Accession 0001570523-18-000013

CIK 0001559356other

View on SEC.gov Company Profile

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 2:59 PM ET

Size

47.3 KB

Accession

0001570523-18-000013

Insider Transaction Report

Form 5

Period: 2017-12-31

Immune Therapeutics, Inc.IMUN

DAILEY ROBERT JACKMAN

Other

Transactions

Purchase
Common stock
2016-03-24$0.16/sh+8,750$1,390→ 20,800,359 total
Purchase
Common stock
2016-03-24$0.16/sh+2,000$314→ 20,800,359 total
Purchase
Common stock
2016-03-17$0.17/sh+5,000$850→ 20,800,359 total
Purchase
Common stock
2016-03-18$0.17/sh+10,000$1,685→ 20,800,359 total
Purchase
Common stock
2016-03-24$0.15/sh+20,000$2,920→ 20,800,359 total
Purchase
Common stock
2016-03-24$0.16/sh+1,250$196→ 20,800,359 total
Purchase
Common stock
2016-03-24$0.16/sh+781$124→ 20,800,359 total
Purchase
Common stock
2016-03-24$0.16/sh+4,219$670→ 20,800,359 total
Purchase
Common stock
2016-03-16$0.18/sh+1,000$180→ 20,800,359 total
Purchase
Common stock
2016-03-16$0.18/sh+3,750$675→ 20,800,359 total
Purchase
Common stock
2016-03-16$0.18/sh+1,200$218→ 20,800,359 total
Purchase
Common stock
2016-03-16$0.19/sh+2,000$380→ 20,800,359 total
Purchase
Common stock
2016-03-16$0.19/sh+1,000$190→ 20,800,359 total
Purchase
Common stock
2016-03-16$0.17/sh+6,900$1,173→ 20,800,359 total
Purchase
Common stock
2016-03-17$0.19/sh+11,200$2,128→ 20,800,359 total
Purchase
Common stock
2016-03-17$0.19/sh+500$94→ 20,800,359 total
Purchase
Common stock
2016-03-18$0.17/sh+1,100$187→ 20,800,359 total
Purchase
Common stock
2016-03-21$0.15/sh+10,000$1,545→ 20,800,359 total
Purchase
Common stock
2016-03-16$0.18/sh+1,000$180→ 20,800,359 total
Purchase
Common stock
2016-03-16$0.18/sh+5,000$900→ 20,800,359 total
Purchase
Common stock
2016-03-16$0.18/sh+1,250$221→ 20,800,359 total
Purchase
Common stock
2016-03-16$0.17/sh+500$83→ 20,800,359 total
Purchase
Common stock
2016-03-16$0.17/sh+6,900$1,167→ 20,800,359 total
Purchase
Common stock
2016-03-21$0.15/sh+1,000$155→ 20,800,359 total
Purchase
Common stock
2016-03-22$0.15/sh+1,603$247→ 20,800,359 total
Purchase
Common stock
2016-03-22$0.15/sh+8,397$1,292→ 20,800,359 total
Purchase
Common stock
2016-03-24$0.16/sh+5,000$782→ 20,800,359 total
Purchase
Common stock
2016-03-24$0.15/sh+40,000$5,840→ 20,800,359 total
Purchase
Common stock
2016-03-24$0.15/sh+20,000$2,920→ 20,800,359 total
Purchase
Common stock
2016-03-24$0.15/sh+20,000$3,000→ 20,800,359 total

Documents

1 file

5
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Immune Therapeutics, Inc.

CIK 0001559356

Entity typeother

Related Parties

1

filerCIK 0001570523

Filing Metadata

Form type: 5
Filed: Mar 29, 8:00 PM ET
Accepted: Mar 30, 2:59 PM ET
Size: 47.3 KB

View on SEC.gov